[Current status of lung cancer care in Germany in the context of treatment centralization and lack of personnel].
Ioannis KarampinisPhilipp SchillerChristian GalataRobert ScheubelRoland BuhlMichael KreuterMartin HetzelThomas VoshaarEric RoessnerPublished in: Pneumologie (Stuttgart, Germany) (2024)
The introduction of the minimum quantity regulation will have significant consequences for the treatment of lung cancer in Germany. The current staff shortage in healthcare will lead to both medical and nursing staff needing to be redistributed in order to meet the needs that will arise in 2025. Operating lists, theatre days, and operative equipment will need to be redistributed as well, not only within hospitals but probably on a nationwide level. A negative impact of the new regulation is to be expected on research and academic activities since most university hospitals are not expected to reach the minimum number of lung resections that is required in order keep performing lung cancer surgery.